Applications of Artificial Intelligence in Peripheral Neuropathy: A Systematic Review
DOI:
https://doi.org/10.19166/med.v13i1.10778Keywords:
Artificial intelligence, Deep learning, Machine learning, Peripheral neuropathyAbstract
Background:
Peripheral neuropathy (PN) is a common complication of metabolic and systemic diseases, particularly diabetes mellitus, resulting in sensory loss, pain, and motor impairment. Conventional diagnostic tools often detect PN only after irreversible nerve injury. Artificial intelligence (AI), especially machine learning (ML), has emerged as a promising tool for early diagnosis and risk prediction by integrating clinical, imaging, and genetic data.
Methods:
Following PRISMA 2020 guidelines, PubMed, EMBASE, IEEE Xplore, and Scopus were systematically searched up to September 2025. Studies applying ML or deep learning algorithms to PN were included, while reviews, grey literature, and studies lacking methodological details or performance metrics were excluded.
Result:
Our study included participants with diabetic, chemotherapy-induced, or pain-related neuropathies. Deep learning models, such as multilayer perceptrons and neural networks, achieved diagnostic accuracies of 87–93%, while classical algorithms including random forest, XGBoost, and SVM reported AUCs of 0.80–0.93. Radiomics-based SVMs using ultrasound showed external validation AUCs of 0.70–0.90. Key predictors included HbA1c, diabetes duration, lipid profile, and BMI.
Conclusions:
Machine learning demonstrates strong potential for improving the prediction, diagnosis, and phenotypic classification of PN. However, heterogeneity in datasets and limited external validation restrict clinical translation. Future work should focus on standardized data, multicenter validation, and interpretable AI models to facilitate integration into clinical practice.
References
1. Hammi C, Yeung B. Neuropathy. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Feb 24]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK542220/.
2. Ghosh S, Basuthakur P, Chakravarty S. Peripheral Neuropathy: Pathophysiology, Challenges, and Therapeutic Insights. In: Bennett G, Goodall E, editors. The Palgrave Encyclopedia of Disability [Internet]. Cham: Springer Nature Switzerland; 2025 [cited 2025 Oct 22]. p. 1–21. Available from: https://link.springer.com/10.1007/978-3-031-40858-8_239-1.
3. Bodman MA, Dreyer MA, Varacallo MA. Diabetic Peripheral Neuropathy. StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 [cited 2025 Oct 22]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK442009/.
4. Yang Y, Zhao B, Wang Y, Lan H, Liu X, Hu Y, Cao P. Diabetic neuropathy: cutting-edge research and future directions. Sig Transduct Target Ther. 2025;10:132. doi: 10.1038/s41392-025-02175-1.
5. Hicks CW, Selvin E. Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes. Curr Diab Rep. 2019;19:86. doi: 10.1007/s11892-019-1212-8. Cited: in: : PMID: 31456118.
6. Perveen W, Ahsan H, Rameen Shahzad, Fayyaz S, Zaif A, Paracha MA, Nuhmani S, Khan M, Alghadir AH. Prevalence of peripheral neuropathy, amputation, and quality of life in patients with diabetes mellitus. Sci Rep. 2024;14:14430. doi: 10.1038/s41598-024-65495-2.
7. Sun M, Sun X, Wang F, Liu L. Machine learning-based prediction of diabetic peripheral neuropathy: model development and clinical validation. Front Endocrinol (Lausanne). 2025;16:1614657. doi: 10.3389/fendo.2025.1614657. Cited: in: : PMID: 40538804.
8. Li Y, Chang X, Wu J, Liu Y, Wang H, Zhang Y. Machine learning in early diagnosis of neurological diseases: Advancing accuracy and overcoming challenges. Brain Network Disorders. 2025;1:132–139. doi: 10.1016/j.bnd.2025.04.001.
9. Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan SE, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;n71. doi: 10.1136/bmj.n71.
10. Baskozos G, Themistocleous AC, Hebert HL, Pascal MMV, John J, Callaghan BC, Laycock H, Granovsky Y, Crombez G, Yarnitsky D, et al. Classification of painful or painless diabetic peripheral neuropathy and identification of the most powerful predictors using machine learning models in large cross-sectional cohorts. BMC Med Inform Decis Mak. 2022;22:144. doi: 10.1186/s12911-022-01890-x.
11. Jiang Y, Peng R, Liu X, Xu M, Shen H, Yu Z, Jiang Z. A Co-Plane Machine Learning Model Based on Ultrasound Radiomics for the Evaluation of Diabetic Peripheral Neuropathy. Acad Radiol. 2025;32:6059–6071. doi: 10.1016/j.acra.2025.07.044. Cited: in: : PMID: 40783342.
12. Kazemi M, Moghimbeigi A, Kiani J, Mahjub H, Faradmal J. Diabetic peripheral neuropathy class prediction by multicategory support vector machine model: a cross-sectional study. Epidemiol Health. 2016;38:e2016011. doi: 10.4178/epih.e2016011. Cited: in: : PMID: 27032459.
13. Shi G, Gao Z, Zhang Z, Jin Q, Li S, Liu J, Kou L, Aerman A, Yang W, Wang Q, et al. Machine learning‐based risk prediction model for neuropathic foot ulcers in patients with diabetic peripheral neuropathy. J of Diabetes Invest. 2025;16:1055–1064. doi: 10.1111/jdi.70010.
14. Wu Y, Dong D, Zhu L, Luo Z, Liu Y, Xie X. Interpretable machine learning models for detecting peripheral neuropathy and lower extremity arterial disease in diabetics: an analysis of critical shared and unique risk factors. BMC Med Inform Decis Mak. 2024;24:200. doi: 10.1186/s12911-024-02595-z.
15. Xiao M-X, Lu C-H, Ta N, Wei H-C, Haryadi B, Wu H-T. Machine learning prediction of future peripheral neuropathy in type 2 diabetics with percussion entropy and body mass indices. Biocybernetics and Biomedical Engineering. 2021;41:1140–1149. doi: 10.1016/j.bbe.2021.08.001.
16. Xiao M, Lu C, Ta N, Wei H, Yang C, Wu H. Toe PPG sample extension for supervised machine learning approaches to simultaneously predict type 2 diabetes and peripheral neuropathy. Biomedical Signal Processing and Control. 2022;71:103236. doi: 10.1016/j.bspc.2021.103236.
17. Yamada H, Ohmori R, Okada N, Nakamura S, Kagawa K, Fujii S, Miki H, Ishizawa K, Abe M, Sato Y. A machine learning model using SNPs obtained from a genome-wide association study predicts the onset of vincristine-induced peripheral neuropathy. Pharmacogenomics J. 2022;22:241–246. doi: 10.1038/s41397-022-00282-8.
18. Chung T, Prasad K, Lloyd TE. Peripheral neuropathy: clinical and electrophysiological considerations. Neuroimaging Clin N Am. 2014;24:49–65. doi: 10.1016/j.nic.2013.03.023. Cited: in: : PMID: 24210312.
19. Uncini A, Santoro L. The electrophysiology of axonal neuropathies: More than just evidence of axonal loss. Clinical Neurophysiology. 2020;131:2367–2374. doi: 10.1016/j.clinph.2020.07.014.
20. Yang Q, Bee YM, Lim CC, Sabanayagam C, Yim-Lui Cheung C, Wong TY, Ting DSW, Lim L-L, Li H, He M, et al. Use of artificial intelligence with retinal imaging in screening for diabetes-associated complications: systematic review. eClinicalMedicine. 2025;81:103089. doi: 10.1016/j.eclinm.2025.103089.
21. Liu Y-F, Ji Y-K, Fei F-Q, Chen N-M, Zhu Z-T, Fei X-Z. Research progress in artificial intelligence assisted diabetic retinopathy diagnosis. Int J Ophthalmol. 2023;16:1395–1405. doi: 10.18240/ijo.2023.09.05. Cited: in: : PMID: 37724288.
22. Kim MS, Choi YW, Prakash BS, Lee Y, Lim S, Woo SJ. A machine learning-based prediction of diabetic retinopathy using the Korea national health and nutrition examination survey (2008-2012, 2017-2021). Front Med (Lausanne). 2025;12:1542860. doi: 10.3389/fmed.2025.1542860. Cited: in: : PMID: 40520799.
23. Wang F, Ma A, Wu Z, Xie M, Lun P, Sun P. Development and validation of radiomics models for the prediction of diagnosis of classic trigeminal neuralgia. Front Neurosci. 2023;17:1188590. doi: 10.3389/fnins.2023.1188590. Cited: in: : PMID: 37877009.
24. Huang W, Shu N. AI-powered integration of multimodal imaging in precision medicine for neuropsychiatric disorders. Cell Rep Med. 2025;6:102132. doi: 10.1016/j.xcrm.2025.102132. Cited: in: : PMID: 40398391.
25. De Godoy LL, Chawla S, Brem S, Mohan S. Taming Glioblastoma in “Real Time”: Integrating Multimodal Advanced Neuroimaging/AI Tools Towards Creating a Robust and Therapy Agnostic Model for Response Assessment in Neuro-Oncology. Clinical Cancer Research. 2023;29:2588–2592. doi: 10.1158/1078-0432.CCR-23-0009.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Anak Agung Ngurah Agung Bayu Sutha, Sharon, Dea Nabila Rahman, Salma Rizqi Amanah, Teguh Budi Wicaksono, Dina Sofiana, Galih Muchlis Hermawan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-SA 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website). The final published PDF should be used and bibliographic details that credit the publication in this journal should be included.
